These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

821 related articles for article (PubMed ID: 16271908)

  • 1. Prescription of teratogenic medications in United States ambulatory practices.
    Schwarz EB; Maselli J; Norton M; Gonzales R
    Am J Med; 2005 Nov; 118(11):1240-9. PubMed ID: 16271908
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Provision of potentially teratogenic medications to female veterans of childbearing age.
    Schwarz EB; Longo LS; Zhao X; Stone RA; Cunningham F; Good CB
    Med Care; 2010 Sep; 48(9):834-42. PubMed ID: 20706159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of the prescribing of potentially inappropriate medications at ambulatory care visits by elderly patients covered by the Taiwanese National Health Insurance program.
    Lai HY; Hwang SJ; Chen YC; Chen TJ; Lin MH; Chen LK
    Clin Ther; 2009 Aug; 31(8):1859-70. PubMed ID: 19808145
    [TBL] [Abstract][Full Text] [Related]  

  • 4. National patterns of medication use during pregnancy.
    Lee E; Maneno MK; Smith L; Weiss SR; Zuckerman IH; Wutoh AK; Xue Z
    Pharmacoepidemiol Drug Saf; 2006 Aug; 15(8):537-45. PubMed ID: 16700083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Physician and patient factors associated with the prescribing of medications for sleep difficulties that are associated with high abuse potential or are expensive: an analysis of data from the National Ambulatory Medical Care Survey for 1996-2001.
    Rasu RS; Shenolikar RA; Nahata MC; Balkrishnan R
    Clin Ther; 2005 Dec; 27(12):1970-9. PubMed ID: 16507384
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Informing patients of the teratogenic potential of mood stabilizing drugs: a case note review of the practice of psychiatrists.
    James L; Barnes TR; Lelliott P; Taylor D; Paton C
    J Psychopharmacol; 2007 Nov; 21(8):815-9. PubMed ID: 17881432
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Opportunities missed: improving the rate of contraceptive counseling or provision when prescribing reproductive-aged women potentially teratogenic medications in a family medicine resident clinic.
    Fritsche MD; Ables AZ; Bendyk H
    Contraception; 2011 Oct; 84(4):372-6. PubMed ID: 21920192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-Risk Medication Prescriptions in Primary Care for Women Without Documented Contraception.
    Panchal BD; Cash R; Moreno C; Vrontos E; Bourne C; Palmer S; Simpson A; Panchal AR
    J Am Board Fam Med; 2019; 32(4):474-480. PubMed ID: 31300567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adherence to oral contraception in women on Category X medications.
    Steinkellner A; Chen W; Denison SE
    Am J Med; 2010 Oct; 123(10):929-934.e1. PubMed ID: 20920695
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors affecting prescription of ultra-high potency topical corticosteroids in skin disease: an analysis of US national practice data.
    Balkrishnan R; Camacho FT; Pearce DJ; Kulkarni AS; Spencer L; Fleischer AB; Feldman SR
    J Drugs Dermatol; 2005; 4(6):699-706. PubMed ID: 16302555
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inappropriate medication prescribing for elderly ambulatory care patients.
    Goulding MR
    Arch Intern Med; 2004 Feb; 164(3):305-12. PubMed ID: 14769626
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Documentation of contraception and pregnancy when prescribing potentially teratogenic medications for reproductive-age women.
    Schwarz EB; Postlethwaite DA; Hung YY; Armstrong MA
    Ann Intern Med; 2007 Sep; 147(6):370-6. PubMed ID: 17876020
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contraceptive counseling of diabetic women of reproductive age.
    Schwarz EB; Maselli J; Gonzales R
    Obstet Gynecol; 2006 May; 107(5):1070-4. PubMed ID: 16648413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Teratogenic medications and concurrent contraceptive use in women of childbearing ability with epilepsy.
    Bhakta J; Bainbridge J; Borgelt L
    Epilepsy Behav; 2015 Nov; 52(Pt A):212-7. PubMed ID: 26460786
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of prescription medications with a potential for fetal harm among pregnant women.
    Andrade SE; Raebel MA; Morse AN; Davis RL; Chan KA; Finkelstein JA; Fortman KK; McPhillips H; Roblin D; Smith DH; Yood MU; Platt R; H Gurwitz J
    Pharmacoepidemiol Drug Saf; 2006 Aug; 15(8):546-54. PubMed ID: 16586470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prescribing trends by nurse practitioners and physician assistants in the United States.
    Cipher DJ; Hooker RS; Guerra P
    J Am Acad Nurse Pract; 2006 Jun; 18(6):291-6. PubMed ID: 16719848
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Private physicians' provision of contraceptive services.
    Landry DJ; Forrest JD
    Fam Plann Perspect; 1996; 28(5):203-9. PubMed ID: 8886763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pattern of prescriptions issued by nursing home-based physicians versus office-based physicians for frail elderly patients in German nursing homes.
    Pittrow D; Krappweis J; Rentsch A; Schindler C; Hach I; Bramlage P; Kirch W
    Pharmacoepidemiol Drug Saf; 2003; 12(7):595-9. PubMed ID: 14558183
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Missed opportunities for chlamydia screening of young women in the United States.
    Hoover K; Tao G
    Obstet Gynecol; 2008 May; 111(5):1097-102. PubMed ID: 18448741
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Medication therapy in ambulatory medical care: United States, 2003-04.
    Raofi S; Schappert SM
    Vital Health Stat 13; 2006 Dec; (163):1-40. PubMed ID: 17212167
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 42.